Your browser doesn't support javascript.
loading
An updated systematic review and meta-analysis about the safety and efficacy of infliximab biosimilar, CT-P13, for patients with inflammatory bowel disease.
Ebada, Mahmoud Ahmed; Elmatboly, Abdelmagid M; Ali, Ahmed Said; Ibrahim, Ahmed Mohamed; Fayed, Notila; Faisal, Ahmed Faisal; Alkanj, Souad.
Affiliation
  • Ebada MA; Faculty of Medicine, Zagazig University, Zagazig, El-Sharkia, Egypt. mahmoud011467@gmail.com.
  • Elmatboly AM; Medical Research Group of Egypt (MRGE), Zagazig, El-Sharkia, Egypt. mahmoud011467@gmail.com.
  • Ali AS; Zagazig University Hospitals, Zagazig University, Zagazig, El-Sharkia, Egypt. mahmoud011467@gmail.com.
  • Ibrahim AM; Medical Research Group of Egypt (MRGE), Zagazig, El-Sharkia, Egypt.
  • Fayed N; Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
  • Faisal AF; Medical Research Group of Egypt (MRGE), Zagazig, El-Sharkia, Egypt.
  • Alkanj S; Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Int J Colorectal Dis ; 34(10): 1633-1652, 2019 Oct.
Article in En | MEDLINE | ID: mdl-31492986
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Biosimilar Pharmaceuticals / Infliximab / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Int J Colorectal Dis Journal subject: GASTROENTEROLOGIA Year: 2019 Type: Article Affiliation country: Egypt
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Biosimilar Pharmaceuticals / Infliximab / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Int J Colorectal Dis Journal subject: GASTROENTEROLOGIA Year: 2019 Type: Article Affiliation country: Egypt